Home HPTN
Structure
Research
Sites
Community Ethics Prevention
Science
HPTN Studies Network
Information
Site Map

Study Status Table

 

Studies & Sites Table

 

Studies by Country

 

Studies by Research Area

 

Study Phase Definitions


HPTN 052
A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples

Navigation

052 Quick Links

Study Information

HPTN 052 Protocol

HPTN 052 Letters of Amendment

HPTN 052 Clarification Memos

HPTN 052 CRFs

HPTN 052 SSP

HPTN 052 Protocol Deviations

HPTN 052 Safety Information

HPTN 052 SD & Forms

HPTN 052 Resources

HPTN 052 Oversight

HPTN 052 Training

HPTN 052 Lab

HPTN 052 Q&A

HPTN 052 Recruitment Resources

HPTN 052 Related Links

HPTN 052 Alias Lists

HPTN 052 Collaboration Portal

HPTN 052 SCHARP Atlas Portal

Study Oversight

Several committees provide oversight and review of HPTN 052.  This website provides information regarding the membership and activities of these committees.

  • Clinical Management Committee (CMC)
    • The CMC is responsible for answering clinically-related questions. Questions to this committee can include, but are not limited to:
      • Questions about inclusion and exclusion criteria for particular participants
      • Questions about protocol interpretation
      • Questions about ART management (e.g., regimen change or toxicity management)
      • Questions about primary HIV care
      • Questions about the clinical management of co-morbidities
      • Questions about the prophylaxis and treatment of OIs
      • Questions about AE management
      • Questions about grading and reporting AEs and EAEs
    • Clinically-related questions may be submitted to the CMC by sending email to 052CMC@HPTN.org
    • CMC Roster
    • CMC Schedule (Feb 2008 - Sep 2008) (17 Mar 2008)
    • CMC Schedule (Sep 2008 - Apr 2009) (Effective September 14, 2008)
    • CMC Questions and Answers
      

Send any questions or comments regarding this site to: hptn@fhi.org
Please read the HPTN Disclaimer

National Institutes of Health

National Institute of Allergy and Infectious Diseases

This page was last updated: November 06, 2008